Showing results (351-360 of 914) with videos related to
Sort By:
Pageof 92
Psychopharmacologia|December 31, 1975
Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatumC Pycock, D Tarsy, C D MarsdenNeurology|October 1, 1990
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyJ Rivest, N Quinn, C D MarsdenClinical Neuropharmacology|April 1, 1997
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesiasF Stocchi, G Nordera, C D MarsdenBiofeedback and Self-Regulation|December 1, 1991
EMG biofeedback treatment of torticollis: a controlled outcome studyM Jahanshahi, G Sartory, C D MarsdenJournal of the Neurological Sciences|March 1, 1993
Reduction in cortical 5-HT3 binding sites following a unilateral 6-hydroxydopamine lesion of the medial forebrain bundle in ratsL Cicin-Sain, P JennerNeuroscience Letters|May 2, 2000
Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor releaseK S McNaught, P JennerJournal of Neurochemistry|December 3, 1999
Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-culturesK S McNaught, P JennerInternational Journal of Clinical Pharmacology and Biopharmacy|July 1, 1975
Metabolic N-oxidation products of aliphatic amines as potential mediators in amine pharmacologyJ W Gorrod, P JennerNeuroscience Letters|January 4, 2001
Proteasomal function is impaired in substantia nigra in Parkinson's diseaseK S McNaught, P JennerPageof 92